Investors

We are committed to enabling patients with degenerative retinal disorders to enjoy life without the fear of blindness.

Investors

We are committed to enabling patients with degenerative retinal disorders to enjoy life without the fear of blindness.

There are millions of people affected by degenerative retinal disorders worldwide. A number of approaches continue to be explored to treat AMD and RP. Current state of the art with any these technologies is at best limited to simple light perception and very limited fields of view.

Nanovison is developing a completely novel nanotechnology approach to retinal prosthesis: We bundle together arrays of light sensitive optoelectronic nanowires into small sized electrodes that form the core of a neural retinal stimulation system. This is at the very core of what our optoelectronic nanowires can achieve by how we electronically and optically control and modulate their output. It is what sets us apart in a way that no competitor can compete.

We are the first group to show that an optoelectronic nanowire technology can successfully achieve photoelectronic stimulation of the retina and retinal tissues.

Ready to learn more?

Our technology is singularly unique in how the sub retinal device tailors the electrical neural stimulation parameters to the individual patient. It is the most advanced technology available capable of achieving such a degree of patient specificity.